Literature DB >> 19215603

Use of supervised injection facilities and injection risk behaviours among young drug injectors.

María J Bravo1, Luis Royuela, Luis De la Fuente, María T Brugal, Gregorio Barrio, Antonia Domingo-Salvany.   

Abstract

AIMS: To study the use of supervised injection facilities (SIFs) as a predictor of safer injecting practices.
DESIGN: Cross-sectional study conducted with face-to-face interview using a structured questionnaire with computer-assisted personal interviewing. Dried blood spot samples were collected for human immunodeficiency virus (HIV) and hepatitis C virus (HCV) antibody testing.
SETTING: All participants were street-recruited by chain referral methods in Madrid and Barcelona. PARTICIPANTS: A total of 249 young heroin drug injectors recruited by the ITINERE cohort study in two Spanish cities with SIFs. MEASUREMENTS: The main outcome measures were self-reported injecting behaviours and SIFs attendance.
RESULTS: SIF users were more marginalized socially than non-users. They were also more often regular injectors (weekly or more versus sporadic) [odds ratio (OR) = 4.9, 95% confidence interval (CI): 2.7-8.8], speedball users (OR = 2.5, 95% CI: 1.5-4.3) and anti-HCV-positive (OR = 3.1, 95% CI: 1.4-7.1). In the logistic regression analysis, using SIFs was associated independently with not borrowing used syringes (OR = 3.3, 95% CI: 1.4-7.7). However, no significant association was found between SIF use and not sharing injection equipment indirectly (OR = 1.1, 95% CI: 0.5-2.2).
CONCLUSIONS: SIFs attract highly disadvantaged drug injectors who engage none the less in less borrowing of used syringes than non-users of these facilities. The risks of indirect sharing should be emphasized when counselling SIF attendees.

Entities:  

Mesh:

Year:  2009        PMID: 19215603     DOI: 10.1111/j.1360-0443.2008.02474.x

Source DB:  PubMed          Journal:  Addiction        ISSN: 0965-2140            Impact factor:   6.526


  20 in total

1.  Supervised injection sites: prejudice should not trump evidence of benefit.

Authors:  Maria Zlotorzynska; Evan Wood; Julio S Montaner; Thomas Kerr
Journal:  CMAJ       Date:  2013-09-16       Impact factor: 8.262

Review 2.  Public Health and Public Order Outcomes Associated with Supervised Drug Consumption Facilities: a Systematic Review.

Authors:  Mary Clare Kennedy; Mohammad Karamouzian; Thomas Kerr
Journal:  Curr HIV/AIDS Rep       Date:  2017-10       Impact factor: 5.071

3.  Examining the potential role of a supervised injection facility in Saskatoon, Saskatchewan, to avert HIV among people who inject drugs.

Authors:  Ehsan Jozaghi; Asheka Jackson
Journal:  Int J Health Policy Manag       Date:  2015-03-29

4.  Associations between perceived illicit fentanyl use and infectious disease risks among people who inject drugs.

Authors:  Barrot H Lambdin; Ricky N Bluthenthal; Jon E Zibbell; Lynn Wenger; Kelsey Simpson; Alex H Kral
Journal:  Int J Drug Policy       Date:  2019-11-13

5.  Health impacts of a scale-up of supervised injection services in a Canadian setting: an interrupted time series analysis.

Authors:  Mary Clare Kennedy; Kanna Hayashi; M-J Milloy; Miranda Compton; Thomas Kerr
Journal:  Addiction       Date:  2021-12-02       Impact factor: 6.526

Review 6.  HIV and the criminalisation of drug use among people who inject drugs: a systematic review.

Authors:  Kora DeBeck; Tessa Cheng; Julio S Montaner; Chris Beyrer; Richard Elliott; Susan Sherman; Evan Wood; Stefan Baral
Journal:  Lancet HIV       Date:  2017-05-14       Impact factor: 12.767

7.  Supervised injection facility use and exposure to violence among a cohort of people who inject drugs: A gender-based analysis.

Authors:  Mary Clare Kennedy; Kanna Hayashi; M-J Milloy; Jade Boyd; Evan Wood; Thomas Kerr
Journal:  Int J Drug Policy       Date:  2020-03-19

8.  "Another Person Was Going to Do It": The Provision of Injection Drug Use Initiation Assistance in a High-Risk U.S.-Mexico Border Region.

Authors:  Maria L Mittal; Andrew Guise; Claudia Rafful; Patricia Gonzalez-Zuñiga; Peter Davidson; Devesh Vashishtha; Steffanie A Strathdee; Dan Werb
Journal:  Subst Use Misuse       Date:  2019-08-07       Impact factor: 2.164

9.  Detection of infections with hepatitis B virus, hepatitis C virus, and human immunodeficiency virus by analyses of dried blood spots--performance characteristics of the ARCHITECT system and two commercial assays for nucleic acid amplification.

Authors:  R Stefan Ross; Oumaima Stambouli; Nico Grüner; Ulrich Marcus; Wei Cai; Weidong Zhang; Ruth Zimmermann; Michael Roggendorf
Journal:  Virol J       Date:  2013-03-05       Impact factor: 4.099

10.  Recurring Severe Injection-Related Infections in People Who Inject Drugs and the Need for Safe Injection Sites in Madrid, Spain.

Authors:  Jorge Valencia; Jesús Troya; Jeffrey V Lazarus; Guillermo Cuevas; Alejandro Alvaro-Meca; Juan Torres; Carlos Gardeta; David Lozano; Santiago Moreno; Pablo Ryan
Journal:  Open Forum Infect Dis       Date:  2021-05-25       Impact factor: 3.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.